MedPath

Lifileucel

Generic Name
Lifileucel
Drug Type
Biotech
CAS Number
2306267-74-1
Unique Ingredient Identifier
R0835E18NH

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2024/12/19
Phase 3
Recruiting
2024/07/01
Phase 2
Recruiting
2024/06/25
Phase 1
Recruiting
Shanghai Juncell Therapeutics
2024/01/05
Phase 1
Withdrawn
James Isaacs, MD
2023/06/15
Phase 1
Not yet recruiting
Vastra Gotaland Region
2023/02/14
Phase 3
Recruiting
2022/12/07
Phase 1
Active, not recruiting
2022/11/07
Phase 1
Recruiting
2022/01/04
Phase 1
Active, not recruiting
Richard Wu
2021/03/23
Phase 1
Active, not recruiting
Vastra Gotaland Region

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath